Children make up 27% of the world's population, but most therapeutics for brain disease are tested on adults with pediatric clinical trials often following years later. This has led to a significant gap in medical technology for infants and children. UW chemical engineering associate professor Elizabeth Nance is developing therapeutics for newborn and pediatric brain disease, with the goal of improving neurological function and quality of life. Learn more about Nance’s work to expand brain health options through these early stages of life.
Elizabeth Nance, Jagjeet and Janice Bindra Endowed Career Development Associate Professor of Chemical Engineering
10/26/22
Негізгі бет Engineering therapies for the pediatric brain
No video
Пікірлер: 1